Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2161

1.

Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy.

Banna GL, Camerini A, Bronte G, Anile G, Addeo A, Rundo F, Zanghì G, Lal R, Libra M.

Anticancer Res. 2018 Jun;38(6):3689-3697. doi: 10.21873/anticanres.12647.

PMID:
29848729
2.

Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors.

Carella AM, Corradini P, Mussetti A, Ricardi U, Vitolo U, Viviani S.

Ann Hematol. 2018 Aug;97(8):1301-1315. doi: 10.1007/s00277-018-3366-x. Epub 2018 May 25. Review.

PMID:
29802458
3.

[Role of Pharmacists in Completion of Adjuvant Cisplatin-Vinorelbine Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer].

Morimoto Y, Takei H, Tachibana K, Nakazato Y, Tanaka R, Nagashima Y, Watanabe K, Seki R, Shinohara T, Kondo H.

Yakugaku Zasshi. 2018;138(3):437-442. doi: 10.1248/yakushi.17-00192. Japanese.

4.

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.

Hisakane K, Yoh K, Nakamura N, Udagawa H, Kirita K, Umemura S, Matsumoto S, Niho S, Akimoto T, Tsuboi M, Goto K.

Medicine (Baltimore). 2017 Nov;96(47):e8635. doi: 10.1097/MD.0000000000008635.

5.

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer.

Chen TW, Yeh DC, Chao TY, Lin CH, Chow LW, Chang DY, Hsieh YY, Huang SM, Cheng AL, Lu YS, Consortium TBC.

Jpn J Clin Oncol. 2018 Mar 1;48(3):242-247. doi: 10.1093/jjco/hyx188.

PMID:
29315394
6.

Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution.

Bartlett NL.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):317-323. doi: 10.1182/asheducation-2017.1.317. Review.

PMID:
29222273
7.

Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma.

Berthold F, Hömberg M, Proleskovskaya I, Mazanek P, Belogurova M, Ernst A, Sterba J.

Pediatr Hematol Oncol. 2017 Aug;34(5):308-319. doi: 10.1080/08880018.2017.1373314. Epub 2017 Nov 17.

PMID:
29148865
8.

Inhibition of survivin expression after using oxaliplatin and vinflunine to induce cytogenetic damage in vitro in lymphocytes from colon cancer patients and healthy individuals.

Alotaibi AAA, Najafzadeh M, Davies JD, Baumgartner A, Anderson D.

Mutagenesis. 2017 Oct 17;32(5):517-524. doi: 10.1093/mutage/gex022.

PMID:
29040706
9.

Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.

He K, Wang X, Guan X, Yu Q, Ma Q, Liu Z, Yu Z.

Anticancer Res. 2017 Oct;37(10):5647-5653.

PMID:
28982882
11.

Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen.

Tarek N, Hayes-Jordan A, Salvador L, McAleer MF, Herzog CE, Huh WW.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26768. Epub 2017 Sep 22.

PMID:
28941151
12.

Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy.

Zubizarreta PA, Alfaro E, Guitter M, Sanchez La Rosa C, Galluzzo ML, Millán N, Fiandrino F, Felice MS.

J Pediatr Hematol Oncol. 2017 Nov;39(8):602-608. doi: 10.1097/MPH.0000000000000943.

PMID:
28902084
13.

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Franklin J, Eichenauer DA, Becker I, Monsef I, Engert A.

Cochrane Database Syst Rev. 2017 Sep 13;9:CD008814. doi: 10.1002/14651858.CD008814.pub2. Review.

PMID:
28901021
14.

Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).

Passalacqua R, Lazzarelli S, Donini M, Montironi R, Tambaro R, De Giorgi U, Pignata S, Palumbo R, Ceresoli GL, Del Conte G, Tonini G, Morelli F, Nolè F, Panni S, Rondini E, Guida A, Zucali PA, Doni L, Iezzi E, Caminiti C.

BMC Cancer. 2017 Jul 19;17(1):493. doi: 10.1186/s12885-017-3466-3.

15.

Clinical and subclinical cardiac late effects in pediatric Hodgkin's lymphoma survivors.

Materazzo C, Massimino M, Schiavello E, Podda M, Gandola L, Cefalo G, Catania S, Meazza C, Moschetti I, Terenziani M.

Tumori. 2017 Nov 23;103(6):566-571. doi: 10.5301/tj.5000670. Epub 2017 Jul 8.

PMID:
28708228
16.

Group IV nociceptors develop axonal chemical sensitivity during neuritis and following treatment of the sciatic nerve with vinblastine.

Govea RM, Barbe MF, Bove GM.

J Neurophysiol. 2017 Oct 1;118(4):2103-2109. doi: 10.1152/jn.00395.2017. Epub 2017 Jul 12.

17.

Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

Yamamura J, Masuda N, Yamamoto D, Tsuyuki S, Yamaguchi M, Tanaka S, Tsurutani J, Tokunaga S, Yoshidome K, Mizutani M, Aono T, Ooe A, Tanino H, Matsunami N, Yasojima H, Nakayama T, Nishida Y.

Chemotherapy. 2017;62(5):307-313. doi: 10.1159/000475879. Epub 2017 Jun 13.

PMID:
28605730
18.

Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.

Dann EJ, Bairey O, Bar-Shalom R, Mashiach T, Barzilai E, Kornberg A, Akria L, Tadmor T, Filanovsky K, Abadi U, Kagna O, Ruchlemer R, Abdah-Bortnyak R, Goldschmidt N, Epelbaum R, Horowitz NA, Lavie D, Ben-Yehuda D, Shpilberg O, Paltiel O.

Br J Haematol. 2017 Sep;178(5):709-718. doi: 10.1111/bjh.14734. Epub 2017 Jun 7.

PMID:
28589704
19.

Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.

Mencoboni M, Filiberti RA, Taveggia P, Del Corso L, Del Conte A, Covesnon MG, Puccetti C, Donati S, Auriati L, Amoroso D, Camerini A.

Anticancer Res. 2017 Jun;37(6):3189-3194.

PMID:
28551663
20.

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.

Skoetz N, Will A, Monsef I, Brillant C, Engert A, von Tresckow B.

Cochrane Database Syst Rev. 2017 May 25;5:CD007941. doi: 10.1002/14651858.CD007941.pub3. Review.

PMID:
28541603

Supplemental Content

Loading ...
Support Center